Prokidney Corp. (PROK)

1.05 USD-7.52%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap—52 Week Range: 1.05 – 2.57
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.—
The live quote provider is unreachable; the last known close is shown.

Prokidney Corp. (PROK) is not among the 30 most-held stocks of the tracked superinvestor set. Price 1.04 USD.

Price & valuation

Prev Close1.13
Open—
Day Range—
52 Week Range1.05 – 2.57
Volume—
Avg Volume (3M)—
Market Cap—
BetaVolatility vs the market. Above 1: swings harder than the index.2.092 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.—
EPS (TTM)Annual net profit per share.—
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own PROK?

Prokidney Corp. (PROK) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on PROK bullish or bearish?

PROK is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.